Literature DB >> 26468169

Translating preclinical hopes into clinical reality for children with ependymoma.

Jacques Grill1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26468169      PMCID: PMC4633936          DOI: 10.1093/neuonc/nov240

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  14 in total

1.  A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat.

Authors:  Till Milde; Susanne Kleber; Andrey Korshunov; Hendrik Witt; Thomas Hielscher; Philipp Koch; Hans-Georg Kopp; Manfred Jugold; Hedwig E Deubzer; Ina Oehme; Marco Lodrini; Hermann-Josef Gröne; Axel Benner; Oliver Brüstle; Richard J Gilbertson; Andreas von Deimling; Andreas E Kulozik; Stefan M Pfister; Ana Martin-Villalba; Olaf Witt
Journal:  Acta Neuropathol       Date:  2011-08-24       Impact factor: 17.088

2.  Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.

Authors:  Maryam Fouladi; Clinton F Stewart; James Olson; Lars M Wagner; Arzu Onar-Thomas; Mehmet Kocak; Roger J Packer; Stewart Goldman; Sridharan Gururangan; Amar Gajjar; Tim Demuth; Larry E Kun; James M Boyett; Richard J Gilbertson
Journal:  J Clin Oncol       Date:  2011-08-08       Impact factor: 44.544

3.  Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study.

Authors:  Sridharan Gururangan; Jason Fangusaro; Tina Young Poussaint; Arzu Onar-Thomas; Richard J Gilbertson; Sridhar Vajapeyam; Amar Gajjar; Stewart Goldman; Henry S Friedman; Roger J Packer; James M Boyett; Larry E Kun; Roger McLendon
Journal:  Neuro Oncol       Date:  2012-09-26       Impact factor: 12.300

4.  An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma.

Authors:  Jennifer M Atkinson; Anang A Shelat; Angel Montero Carcaboso; Tanya A Kranenburg; Leggy A Arnold; Nidal Boulos; Karen Wright; Robert A Johnson; Helen Poppleton; Kumarasamypet M Mohankumar; Clementine Féau; Timothy Phoenix; Paul Gibson; Liqin Zhu; Yiai Tong; Chris Eden; David W Ellison; Waldemar Priebe; Dimpy Koul; W K Alfred Yung; Amar Gajjar; Clinton F Stewart; R Kiplin Guy; Richard J Gilbertson
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

5.  Epigenomic alterations define lethal CIMP-positive ependymomas of infancy.

Authors:  S C Mack; H Witt; R M Piro; L Gu; S Zuyderduyn; A M Stütz; X Wang; M Gallo; L Garzia; K Zayne; X Zhang; V Ramaswamy; N Jäger; D T W Jones; M Sill; T J Pugh; M Ryzhova; K M Wani; D J H Shih; R Head; M Remke; S D Bailey; T Zichner; C C Faria; M Barszczyk; S Stark; H Seker-Cin; S Hutter; P Johann; S Bender; V Hovestadt; T Tzaridis; A M Dubuc; P A Northcott; J Peacock; K C Bertrand; S Agnihotri; F M G Cavalli; I Clarke; K Nethery-Brokx; C L Creasy; S K Verma; J Koster; X Wu; Y Yao; T Milde; P Sin-Chan; J Zuccaro; L Lau; S Pereira; P Castelo-Branco; M Hirst; M A Marra; S S Roberts; D Fults; L Massimi; Y J Cho; T Van Meter; W Grajkowska; B Lach; A E Kulozik; A von Deimling; O Witt; S W Scherer; X Fan; K M Muraszko; M Kool; S L Pomeroy; N Gupta; J Phillips; A Huang; U Tabori; C Hawkins; D Malkin; P N Kongkham; W A Weiss; N Jabado; J T Rutka; E Bouffet; J O Korbel; M Lupien; K D Aldape; G D Bader; R Eils; P Lichter; P B Dirks; S M Pfister; A Korshunov; M D Taylor
Journal:  Nature       Date:  2014-02-19       Impact factor: 49.962

6.  An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes.

Authors:  Kumarasamypet M Mohankumar; David S Currle; Elsie White; Nidal Boulos; Jason Dapper; Christopher Eden; Birgit Nimmervoll; Radhika Thiruvenkatam; Michele Connelly; Tanya A Kranenburg; Geoffrey Neale; Scott Olsen; Yong-Dong Wang; David Finkelstein; Karen Wright; Kirti Gupta; David W Ellison; Arzu Onar Thomas; Richard J Gilbertson
Journal:  Nat Genet       Date:  2015-06-15       Impact factor: 38.330

7.  EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell.

Authors:  Phylip Chen; Nathan Rossi; Samuel Priddy; Christopher R Pierson; Adam W Studebaker; Robert A Johnson
Journal:  Sci Rep       Date:  2015-03-24       Impact factor: 4.379

8.  Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.

Authors:  Catherine S Grasso; Yujie Tang; Nathalene Truffaux; Noah E Berlow; Lining Liu; Marie-Anne Debily; Michael J Quist; Lara E Davis; Elaine C Huang; Pamelyn J Woo; Anitha Ponnuswami; Spenser Chen; Tessa B Johung; Wenchao Sun; Mari Kogiso; Yuchen Du; Lin Qi; Yulun Huang; Marianne Hütt-Cabezas; Katherine E Warren; Ludivine Le Dret; Paul S Meltzer; Hua Mao; Martha Quezado; Dannis G van Vuurden; Jinu Abraham; Maryam Fouladi; Matthew N Svalina; Nicholas Wang; Cynthia Hawkins; Javad Nazarian; Marta M Alonso; Eric H Raabe; Esther Hulleman; Paul T Spellman; Xiao-Nan Li; Charles Keller; Ranadip Pal; Jacques Grill; Michelle Monje
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

9.  Inhibition of the NOTCH pathway using γ-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumors.

Authors:  Carmela Dantas-Barbosa; Guillaume Bergthold; Estelle Daudigeos-Dubus; Heike Blockus; John F Boylan; Celine Ferreira; Stephanie Puget; Michel Abely; Gilles Vassal; Jacques Grill; Birgit Geoerger
Journal:  Anticancer Drugs       Date:  2015-03       Impact factor: 2.248

10.  C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.

Authors:  Matthew Parker; Kumarasamypet M Mohankumar; Chandanamali Punchihewa; Ricardo Weinlich; James D Dalton; Yongjin Li; Ryan Lee; Ruth G Tatevossian; Timothy N Phoenix; Radhika Thiruvenkatam; Elsie White; Bo Tang; Wilda Orisme; Kirti Gupta; Michael Rusch; Xiang Chen; Yuxin Li; Panduka Nagahawhatte; Erin Hedlund; David Finkelstein; Gang Wu; Sheila Shurtleff; John Easton; Kristy Boggs; Donald Yergeau; Bhavin Vadodaria; Heather L Mulder; Jared Becksfort; Jared Becksford; Pankaj Gupta; Robert Huether; Jing Ma; Guangchun Song; Amar Gajjar; Thomas Merchant; Frederick Boop; Amy A Smith; Li Ding; Charles Lu; Kerri Ochoa; David Zhao; Robert S Fulton; Lucinda L Fulton; Elaine R Mardis; Richard K Wilson; James R Downing; Douglas R Green; Jinghui Zhang; David W Ellison; Richard J Gilbertson
Journal:  Nature       Date:  2014-02-19       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.